l-tyrosine vs l-carnitine 500 mg | Energy & Fat Metabolism Support* L – Tyrosine | LifeKey

2003 (2) CD003158

The lack of specific experimental data and uncertainty in quantitative experimentation is difficult for this AOP, as many factors can simultaneously cause key events (such as an increase in ROS or kidney failure)

Medical Director, Heart and Vascular Center of Excellence Chief, Division of Cardiovascular Medicine University of Massachusetts Medical School and Memorial Medical Center Mary C

Acknowledgements This work was supported by grants from NIH (HL076236-01), American Heart Association Scientist Development Grant and American Diabetes Association to Adviye Ergul and an AHA Southeast Affiliate Predoctoral Fellowship Award to Alex K